Skip to contentS
Surgery Partners, Inc.
S
SGRYSurgery Partners, Inc. Q1 2020 · 10-Q
Revenue$441.00M$441.00M+5.8% vs Q1 2019 Net Income-$27.50M-$27.50MN/M vs Q1 2019 EPS Diluted-$0.76-$0.76N/M vs Q1 2019 Operating Income$23,500,000−52.6% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Surgery Partners, Inc. · CIK 1638833 · Engraved from SEC EDGAR
Free Cash Flowderived$17,400,000+100.0% Margins · derivedOperating margin5.3%−6.6 pt vs Q1 2019
Net margin-6.2%−1.4 pt vs Q1 2019
ended Mar 31, 2020 · filed May 11, 2020 · 41 d after period end